UAB Pulmonary, Allergy, and Critical Care Medicine

The final presentation for the will be Jessy Deshane, PhD discussing Spatial Resolution of Response to Combination Immunotherapy for NSCL!

Scott S. Oh, DO, FCCP, delivers his keynote speech on upcoming bronchoscopic therapies at the !

Watch this speech and all of the via Zoom!
https://t.co/tQVTRcceWL

The update moves to a panel discussion, providing perspectives on care from patients, nurses, physicians, and social workers.

Watch this panel and all of the via Zoom!
https://t.co/tQVTRcceWL

The with Aakash Desai, MD providing updated information on clinical trials!

Next up at the is Padma Manapragada, MD, covering Peptide Receptor Radionuclide Therapy in Pulmonary Neuroendocrine Tumors!

The continues with
Maya Khalil, MD discussing targeted therapies.

Day Two of the continues with Benjamin Wei, MD covering complex airway reconstruction.

Day Two of the has begun with an opening speech from Hitesh Batra.


"Our goal should be - No one dies of lung cancer."

We are in the middle of an outstanding key ote address from Annabelle Gurwitch !

Everyone gear up for the first night of the !
Annabelle Gurwitch will be speaking!

CLAIR raises the bar in lung imaging and analytics The Center for Lung Analytics and Imaging Research (CLAIR) will launch at UAB this year to improve diagnosis and monitoring for patients with chronic lung disease. The center brings together experts from nine scientific specialties who will work to establish new methods for lung imaging and other di...

UAB Medicine is conducting a study called the “Randomized Trial of Sedative Choice for Intubation” (RSI) to learn whether, for seriously ill patients who need a breathing machine, ketamine or etomidate is a better sedative medication with regards to blood pressure, oxygen levels, and heart function.

For patients being placed on a breathing machine in the UAB Medicine emergency department or intensive care unit:

-When the doctors feel ketamine would be best, the doctors give the patients ketamine
-When the doctors feel that etomidate would be best, the doctors give the patient etomidate
-When they do not have a preference, the patient participates in the RSI study and is assigned either ketamine or etomidate randomly. This means every patient has a fair and equal chance of getting either drug.

Both drugs are commonly used to place patients on a breathing machine. Both are approved by the FDA.

To learn more about the study, visit the study website at www.pragmaticcriticalcare.org/RSI.